Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000899243-21-010807

Options or other derivatives

  • Chief Operating Officer acquired 63,801 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jacobson Mark L. Chief Operating Officer 2021-03-05 Grant or award · Employee Stock Option (Right to Buy) +41,638 41,638 D
Jacobson Mark L. Chief Operating Officer 2021-03-05 Grant or award · Restricted Stock Units +22,163 22,163 D
Loading xslF345X03/doc4.xml…